Debt-to-equity of Arbutus Biopharma Corp from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Arbutus Biopharma Corp quarterly Debt-to-equity in % history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • Arbutus Biopharma Corp Debt-to-equity for the quarter ending 30 Sep 2025 was 33%, a 3.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Arbutus Biopharma Corp Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 33% +1.2% +3.8% 30 Sep 2025
Q2 2025 34% +1.8% +5.4% 30 Jun 2025
Q1 2025 35% +2.6% +7.8% 31 Mar 2025
Q4 2024 32% -1.2% -3.6% 31 Dec 2024
Q3 2024 32% -2.8% -7.9% 30 Sep 2024
Q2 2024 33% -4.1% -11% 30 Jun 2024
Q1 2024 33% -6.4% -16% 31 Mar 2024
Q4 2023 33% -8.5% -20% 31 Dec 2023
Q3 2023 35% -0.79% -2.2% 30 Sep 2023
Q2 2023 37% +3.8% +11% 30 Jun 2023
Q1 2023 39% +8.1% +26% 31 Mar 2023
Q4 2022 42% +15% +56% 31 Dec 2022
Q3 2022 36% +5.1% +17% 30 Sep 2022
Q2 2022 33% +0.31% +0.94% 30 Jun 2022
Q1 2022 31% -4% -11% 31 Mar 2022
Q4 2021 27% -12% -31% 31 Dec 2021
Q3 2021 31% -11% -26% 30 Sep 2021
Q2 2021 33% -11% -25% 30 Jun 2021
Q1 2021 35% +3.7% +12% 31 Mar 2021
Q4 2020 39% +14% +58% 31 Dec 2020
Q3 2020 41% +23% +122% 30 Sep 2020
Q2 2020 43% +28% +190% 30 Jun 2020
Q1 2020 31% +16% +110% 31 Mar 2020
Q4 2019 24% +9.2% +61% 31 Dec 2019
Q3 2019 19% +0.06% +0.35% 30 Sep 2019
Q2 2019 15% -9.9% -40% 30 Jun 2019
Q1 2019 15% -17% -54% 31 Mar 2019
Q4 2018 15% -25% -62% 31 Dec 2018
Q3 2018 19% -23% -55% 30 Sep 2018
Q2 2018 25% -8.6% -26% 30 Jun 2018
Q1 2018 32% +4% +14% 31 Mar 2018
Q4 2017 40% +13% +46% 31 Dec 2017
Q3 2017 41% +14% +51% 30 Sep 2017
Q2 2017 33% +4.6% +16% 30 Jun 2017
Q1 2017 28% -2.5% -8.2% 31 Mar 2017
Q4 2016 27% -3.8% -12% 31 Dec 2016
Q3 2016 27% -4.4% -14% 30 Sep 2016
Q2 2016 29% -3.2% -10% 30 Jun 2016
Q1 2016 31% -1% -3.3% 31 Mar 2016
Q4 2015 31% +0.82% +2.7% 31 Dec 2015
Q3 2015 32% +3.7% +13% 30 Sep 2015
Q2 2015 32% 30 Jun 2015
Q1 2015 32% 31 Mar 2015
Q4 2014 30% 31 Dec 2014
Q3 2014 28% 30 Sep 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.